Localization of transforming growth factor-β1 and type II receptor in developing normal human prostate and carcinoma tissues

Journal of Histochemistry and Cytochemistry

Volumn 46, Issue 3, 1998, Pages 379-388

  Gerdes, Michael J ^a   Larsen, Melinda ^a   McBride, Lauren ^a   Dang, Truong D ^a   Lu, Bing ^a   Rowley, David R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Development; Human; Prostate; TGF receptor Type II; TGF 1

Indexed keywords

RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MESENCHYME; ORGANOGENESIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROSTATECTOMY; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; STROMA CELL; TISSUE DISTRIBUTION;

EID: 0031908549     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215549804600312     Document Type: Article

References (40)

1. Arrick BA, Lopez AR, Elfman F, Ebner R, Damsky CH, Derynk R (1992) Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J Cell Biol 118:715-726
2. Barcellos-Hoff MH, Derynck R, Tsang ML-S, Weatherbee JA (1994) Transforming growth factor-β activation in irradiated murine mammary gland. J Clin Invest 93:892-899
3. Bratthauer GL (1994) Processing of tissue specimens. In Javois LC, ed. Methods in Molecular Biology. Vol 34. Immunocytochemical Methods and Protocols. Totowa, NJ, Humana Press, 97-104
4. Carruba G, Leake RE, Rinaldi F, Chalmers D, Comito L, Sorci C, Pavone-Macaluso M, Castagnetta LAM (1994) Steroid-growth factor interaction in human prostate cancer. 1. Shorter-term effects of transforming growth factors on growth of human prostate cancer cells. Steroids 59:412-420
5. Chang N-S (1995) Transforming growth factor-β1 induction of novel extracellular matrix proteins that trigger resistance to tumor necrosis factor cytotoxicity in muring L929 fibroblasts. J Biol Chem 270:7765-7772
6. Chang H-L, Gillett N, Figari I, Lopez AR, Palladino MA, Derynck R (1993) Increased transforming growth factor β expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res 53:4391-4398
7. 125I]TGFβ1-binding sites. Endocrinology 135:439-449
8. Ebner R, Chen R, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R (1993) Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260:1344-1348
9. Eklov S, Funa K, Nordgren H, Olofsson A, Kanzaki T, Miyazono K, Nilsson S (1993) Lack of the latent transforming growth factor β binding protein in malignant but not benign prostatic tissue. Cancer Res 53:3193-3197
10. Franzen P, Ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C, Miyazono K (1993) Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75:681-692
11. Guo Y, Jacobs SC, Kyprianou N (1997) Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer. Int J Cancer 71:573-579
12. Herman ME, Katzenellenbogen BS (1994) Alterations in transforming growth factor-α and -β production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Cancer Res 54:5867-5874
13. Huggett AC, Ellis PA, Ford CP, Hampton LL, Rimoldi D, Thorgeirsson SS (1991) Development of resistance to the growth inhibitory effects of transforming growth factor β1 during spontaneous transformation of rat liver epithelial cells. Cancer Res 51:5929-5936
14. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Kozowski K, Lee C (1996) Loss of expression of transforming growth factor β type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin Cancer Res 2:1255-1261
15. Kingsley DM (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146
16. Lieubeau B, Garrigue L, Barbieux I, Meflah K, Gregoire M (1994) The role of transforming growth factor β1 in the fibroblastic reaction associated with rat colorectal tumor development. Cancer Res 54:6526-6532
17. Lin HY, Wang X, Ng-Eaton E, Weinberg RA, Lodish HF (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785
18. Lindstrom P, Bergh A, Holm I, Damber J-E (1996) Expression of transforming growth factor-β1 in rat ventral prostate and Dunning R2227 PAP prostate tumor after castration and estrogen treatment. Prostate 29:209-218
19. Merz VW, Miller GJ, Krebs T, Timme TL, Kadmon D, Park SH, Egawa S, Scardino PT, Thompson TC (1991) Elevated transforming growth factor-β1 and β3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression. Mol Endocrinol 5:503-513
20. Miyazono K, Olofsson A, Colosetti P, Heldin C-H (1991) A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1. EMBO J 10:1091-1101
21. Park K, Kim S-J, Bang Y-J, Park J-G, Kim N-K, Roberts AB, Sporn MB (1994) Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation wth sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91:8772-8776
22. Pepper MS, Belin D, Montesano R, Orci L, Vassalli J-D (1990) Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111:743-755
23. Pierce DF Jr, Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ Jr, Moses HL (1995) Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc Natl Acad Sci USA 92:4254-4258
24. Prins GS, Birch L (1993) Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate lobes after androgen withdrawal and replacement. Endocrinology 132:169-178
25. Prins GS, Birch L (1995) The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 136:1303-1314
26. Prins GS, Birch L, Greene GL (1991) Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 129:3187-3199
27. Rodeck U, Bossier A, Graeven U, Fox FE, Nowell PC, Knabbe C, Kari C (1994) Transforming growth factor β production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res 54:575-581
28. Shi S, Key M, Kalra K (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhanced method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741-748
29. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT, Cullen KJ (1995) Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res 55:2448-2454
30. Sporn MB, Roberts AB (1992) Transforming growth factor-β: recent progress and new challenges. J Cell Biol 119:1017-1021
31. Steiner MS, Barrack ER (1992) Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol 6:15-25
32. Steiner MS, Zhou Z-Z, Tonb DC, Barrack ER (1994) Expression of transforming growth factor-β1 in prostate cancer. Endocrinology 135:2240-2247
33. Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH (1992) Transforming growth factor β1 as a biomarker for prostate cancer. J Cell Biochem 16H:54-61
34. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiher H, Moses H, Rowley DA (1990) A highly immunogertic tumor transfected with a murine transforming growth factor type β1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 87:1486-1490
35. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC (1993) Association of transforming growth factor-β1 with prostate cancer: an immunohistochemical study. Hum Pathol 24:4-9
36. Van Laethem J-L, Deviere J, Resibois A, Rickaert F, Vertongen P, Ohtani H, Cremer M, Miyazono K, Robberecht P (1995) Localization of transforming growth factor β1 and its latent binding protein in human chronic pancreatitis. Gastroenterology 108: 1873-1881
37. Welch DR, Fabra A, Nakajima M (1990) Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87:7678-7682
38. Wheeler TM, Lebovitz RM (1994) Fresh tissue harvest for research from prostatectomy specimens. Prostate 25:274-279
39. Williams RH, Stapleton AMF, Yang G, Truong LD, Rogers E, Timme TL, Wheeler TM, Scardino PT, Thompson TC (1996) Reduced levels of transforming growth factor β receptor type II in human prostate cancer: an immunohistochemical study. Clin Cancer Res 2:635-640
40. Yang EY, Moses HL (1990) Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111: 731-741